These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7755511)

  • 1. Vaccination strategies using viable carrier systems against intracellular pathogens.
    Hess J; Szalay G; Miko D; Gentschev I; Goebel W; Ladel CH; Kaufmann SH
    Behring Inst Mitt; 1994 Dec; (95):67-79. PubMed ID: 7755511
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant vaccines based on translocated effector proteins of Salmonella Pathogenicity Island 2.
    Husseiny MI; Wartha F; Hensel M
    Vaccine; 2007 Jan; 25(1):185-93. PubMed ID: 16887239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of antigen display by attenuated Salmonella typhimurium strains and its impact on protective immunity against listeriosis.
    Hess J; Miko D; Gentschev I; Dietrich G; Goebel W; Mollenkopf HJ; Ladel C; Kaufmann SH
    Behring Inst Mitt; 1997 Feb; (98):160-71. PubMed ID: 9382737
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational design of Salmonella-based vaccination strategies.
    Spreng S; Dietrich G; Weidinger G
    Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for a novel generation of vaccines.
    Kaufmann SH; Fensterle J; Hess J
    Immunobiology; 1999 Dec; 201(2):272-82. PubMed ID: 10631576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The variation of antigen expression: a natural phenomenon utilised for the construction of live recombinant Salmonella vaccines.
    Yan ZX; Meyer TF
    Behring Inst Mitt; 1994 Dec; (95):49-56. PubMed ID: 7755509
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.
    Wallecha A; Carroll KD; Maciag PC; Rivera S; Shahabi V; Paterson Y
    Adv Appl Microbiol; 2009; 66():1-27. PubMed ID: 19203646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
    Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
    Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
    Husseiny MI; Hensel M
    Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Listeria monocytogenes: a dangerous pathogen used as a vector for the new generation of vaccines].
    Tkachuk MV; Iarovinskiĭ FO; Tonevitskiĭ AG
    Vopr Med Khim; 2000; 46(3):256-64. PubMed ID: 11033885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flt3 ligand pretreatment promotes protective immunity to Listeria monocytogenes.
    Gregory SH; Sagnimeni AJ; Zurowski NB; Thomson AW
    Cytokine; 2001 Feb; 13(4):202-8. PubMed ID: 11237427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors.
    Panthel K; Meinel KM; Sevil Domènech VE; Trülzsch K; Rüssmann H
    Int J Med Microbiol; 2008 Jan; 298(1-2):99-103. PubMed ID: 17719275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines.
    Husseiny MI; Hensel M
    Vaccine; 2005 Apr; 23(20):2580-90. PubMed ID: 15780440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular bacteria as targets and carriers for vaccination.
    Mollenkopf H; Dietrich G; Kaufmann SH
    Biol Chem; 2001 Apr; 382(4):521-32. PubMed ID: 11405217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
    Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
    Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Listeria monocytogenes as an alternative vaccine vector for HIV.
    Mata M; Paterson Y
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):151-62. PubMed ID: 10912619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oral Salmonella vaccine promotes the down-regulation of cell surface Toll-like receptor 4 (TLR4) and TLR2 expression in mice.
    Eguchi M; Sekiya Y; Suzuki M; Yamamoto T; Matsui H
    FEMS Immunol Med Microbiol; 2007 Aug; 50(3):300-8. PubMed ID: 17451442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed population approach for vaccination with live recombinant Salmonella strains.
    Yan ZX; Meyer TF
    J Biotechnol; 1996 Jan; 44(1-3):197-201. PubMed ID: 8717404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Listeria monocytogenes in mice lacking MHC class Ia molecules.
    Seaman MS; Pérarnau B; Lindahl KF; Lemonnier FA; Forman J
    J Immunol; 1999 May; 162(9):5429-36. PubMed ID: 10228021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.